Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Solitary Fibrous Tumors × Sarcoma × Clear all

Phase

Status

Sponsor Class

OTHER 6 INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 100 Central Nervous System Neoplasms 37 Gliosarcoma 32 Glioblastoma 32 Osteosarcoma 30 Rhabdomyosarcoma 25 Fibrosarcoma 22 Liposarcoma 20 Lymphoma 19 Leiomyosarcoma 19 Hemangiosarcoma 19 Astrocytoma 18 Sarcoma, Synovial 17 Neurofibrosarcoma 17 Neuroectodermal Tumors, Primitive, Peripheral 17 Histiocytoma, Malignant Fibrous 17 Dendritic Cell Sarcoma, Interdigitating 17 Neuroblastoma 16 Malignant mesenchymal tumor 16 Brain Neoplasms 16 Sarcoma, Kaposi 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Burkitt Lymphoma 14 Recurrence 13 Sarcoma, Alveolar Soft Part 12 Ovarian Neoplasms 12 Leukemia 12 Oligodendroglioma 11 Hemangiopericytoma, Malignant 11 Endometrial Neoplasms 11

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03840772 2024-09-20

ERASING

Italian Sarcoma Group

Phase 2 Completed

Sarcoma, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡